Clinical Trial

Validity and Reliability of the Hypertonia Assessment Tool (HAT) in Stroke Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 24, 2026 (before its estimated June 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In this study, the validity and reliability of the Hypertonia Assessment Tool (HAT), which has previously been validated in the pediatric cerebral palsy (CP) population, will be evaluated in adult individuals who have experienced a stroke. The HAT is a specific clinical instrument designed to differentiate subtypes of hypertonia, including spasticity, dystonia, and rigidity. Accurate classification of hypertonia subtypes following stroke is crucial for guiding rehabilitation strategies. However, the HAT has not yet been validated in the adult post-stroke population. This study will be conducted at the Physical Medicine and Rehabilitation Clinic of SBU Fatih Sultan Mehmet Training and Research Hospital. The study aims to evaluate the validity and reliability of the HAT for use in adults with stroke.
Trial Details
NCT Number NCT07429383
Lead Sponsor Fatih Sultan Mehmet Training and Research Hospital
Conditions Stroke, Hypertonia, Dystonia, Rigidity, Hemiplegia
Enrollment 60 participants
Start Date 2026-03-01
Primary Completion 2026-06-01 (estimated)
Study Completion 2026-10-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-24